Form 4: Biostem Technologies CFO Reports Stock Transaction
Insider Transaction (Form 4)
Brandon Poe, Chief Financial Officer of Biostem Technologies, reported multiple transactions in common stock on August 11, 2026.
Summary
- Option exercise/conversion: acquired 10,634 Common Stock on August 11, 2026; holds 56,368 after (Direct).
- Option exercise/conversion: disposed of 10,634 Restricted Stock Units on August 11, 2026; holds 21,591 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Brandon Poe — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 10,634 | — | — | 56,368 |
| 2026-08-11 | Option exercise/conversion | Restricted Stock Units | 10,634 | — | — | 21,591 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (10,634 shares) |
| 2026-08-11 | Option exercise/conversion (10,634 shares) |
Keywords
insider transaction, Form 4, BSEM, BioStem Technologies, Inc., neutral, Brandon Poe
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.